Treating Cerebral Ischemia: Novel Therapeutic Strategies from Experimental Stroke Research

  • Zheng X
  • Haupt M
  • Bähr M
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Although systemic thrombolysis and endovascular treatment have revolutionized modern stroke treatment, the majority of patients do not qualify for either treatment paradigm. Hence, novel adjuvant therapeutic strategies are required. This chapter provides an overview of our current understanding of novel therapeutic strategies in preclinical stroke models. The chapter is organized in three major parts to cover the acute, subacute, and chronic phases of ischemic stroke. The potential of various pharmacological agents, stem cells, microRNAs, and extracellular vesicles as therapeutic avenues along with the progress and challenges are discussed.

Cite

CITATION STYLE

APA

Zheng, X., Haupt, M., Bähr, M., Tatenhorst, L., & Doeppner, T. R. (2021). Treating Cerebral Ischemia: Novel Therapeutic Strategies from Experimental Stroke Research. In Cerebral Ischemia (pp. 165–186). Exon Publications. https://doi.org/10.36255/exonpublications.cerebralischemia.2021.therapy

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free